Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc47a2 | Rat | (R,R)-tramadol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Tramadol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | (S)-nicotine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Nicotine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | 17beta-estradiol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC47A2 mRNA and Estradiol promotes the reaction [ESR2 protein affects the expression of SLC47A2 mRNA] | CTD | PMID:20404318 and PMID:30165855 | Slc47a2 | Rat | 17beta-estradiol | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SLC47A2 mRNA | CTD | PMID:23019147 | Slc47a2 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | Slc47a2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC47A2 mRNA | CTD | PMID:20106945 | Slc47a2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC47A2 mRNA | CTD | PMID:33387578 | Slc47a2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] | CTD | PMID:22419765 and PMID:27989701 | Slc47a2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | decreases activity | ISO | SLC47A2 (Homo sapiens) | 6480464 | Verapamil results in decreased activity of SLC47A2 protein | CTD | PMID:28629854 and PMID:31364238 | Slc47a2 | Rat | 2-Ethyl-1,3-hexanediol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | ethohexadiol affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | 2-palmitoylglycerol | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of SLC47A2 mRNA | CTD | PMID:37199045 | Slc47a2 | Rat | 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Nialamide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | 3-Amino-1-methyl-5H-pyrido[4,3-b]indole | decreases activity | ISO | SLC47A2 (Homo sapiens) | 6480464 | 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole results in decreased activity of SLC47A2 protein | CTD | PMID:30189235 | Slc47a2 | Rat | agmatine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Agmatine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA | CTD | PMID:37567420 | Slc47a2 | Rat | amantadine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Amantadine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | amiloride | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Amiloride inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | amitriptyline | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Amitriptyline inhibits the reaction [SLC47A2 protein results in increased import of Tetraethylammonium] | CTD | PMID:28629854 | Slc47a2 | Rat | atropine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Atropine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | benzo[a]pyrene | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SLC47A2 mRNA | CTD | PMID:20106945 | Slc47a2 | Rat | benzo[a]pyrene | affects methylation | ISO | SLC47A2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLC47A2 promoter | CTD | PMID:27901495 | Slc47a2 | Rat | benzo[a]pyrene | decreases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC47A2 mRNA | CTD | PMID:23735875 | Slc47a2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC47A2 mRNA | CTD | PMID:31163220 | Slc47a2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC47A2 mRNA | CTD | PMID:25181051 | Slc47a2 | Rat | bisphenol A | decreases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLC47A2 mRNA | CTD | PMID:32156529 | Slc47a2 | Rat | bisphenol A | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC47A2 gene | CTD | PMID:31601247 | Slc47a2 | Rat | cadmium atom | increases uptake | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased uptake of Cadmium | CTD | PMID:27871888 | Slc47a2 | Rat | cadmium atom | increases response to substance | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased susceptibility to Cadmium | CTD | PMID:27871888 | Slc47a2 | Rat | cadmium atom | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Cadmium inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] and Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of Cadmium] | CTD | PMID:27871888 | Slc47a2 | Rat | caffeine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Caffeine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | cannabidiol | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of SLC47A2 mRNA | CTD | PMID:33244087 | Slc47a2 | Rat | chloramphenicol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Chloramphenicol affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | cimetidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] and Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of Cadmium] | CTD | PMID:21599003 and PMID:27871888 | Slc47a2 | Rat | cinchonidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | cinchonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | cinchonine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | cinchonine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | clonidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | clonidine (amino form) | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | clonidine (imino form) | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | clothianidin | decreases activity | ISO | SLC47A2 (Homo sapiens) | 6480464 | clothianidin results in decreased activity of SLC47A2 protein | CTD | PMID:31364238 | Slc47a2 | Rat | creatinine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Creatinine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of SLC47A2 mRNA | CTD | PMID:27523638 | Slc47a2 | Rat | cyclosporin A | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLC47A2 mRNA | CTD | PMID:20106945 | Slc47a2 | Rat | D-glucose | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA | CTD | PMID:37567420 | Slc47a2 | Rat | dextran sulfate | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA | CTD | PMID:29950665 | Slc47a2 | Rat | epoxiconazole | increases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SLC47A2 mRNA | CTD | PMID:35436446 | Slc47a2 | Rat | famotidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Famotidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | fructose | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA | CTD | PMID:37567420 | Slc47a2 | Rat | fulvestrant | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC47A2 gene | CTD | PMID:31601247 | Slc47a2 | Rat | genistein | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Genistein results in increased expression of SLC47A2 mRNA | CTD | PMID:23019147 | Slc47a2 | Rat | glucose | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA | CTD | PMID:37567420 | Slc47a2 | Rat | Guanfacine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Guanfacine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | guanidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Guanidine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | histamine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Histamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | imiquimod | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | imiquimod inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | ketoconazole | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Ketoconazole inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | lead(0) | affects expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Lead affects the expression of SLC47A2 mRNA | CTD | PMID:28903495 | Slc47a2 | Rat | mercury dichloride | increases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | Mercuric Chloride results in increased expression of SLC47A2 mRNA | CTD | PMID:27720909 | Slc47a2 | Rat | metformin | increases uptake | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased uptake of Metformin | CTD | PMID:22419765 more ... | Slc47a2 | Rat | metformin | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Cadmium inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] more ... | CTD | PMID:22419765 more ... | Slc47a2 | Rat | methylmercury chloride | increases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of SLC47A2 mRNA | CTD | PMID:27720909 | Slc47a2 | Rat | midodrine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Midodrine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... | CTD | PMID:22419765 | Slc47a2 | Rat | N-methyl-4-phenylpyridinium | increases uptake | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium | CTD | PMID:22419765 | Slc47a2 | Rat | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Ranitidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | naloxone | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Naloxone inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | nickel atom | increases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Nickel results in increased expression of SLC47A2 mRNA | CTD | PMID:24768652 and PMID:25583101 | Slc47a2 | Rat | nicotine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Nicotine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | NMN zwitterion | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Nicotinamide Mononucleotide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | Ondansetron | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Ondansetron inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] and Ondansetron inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] | CTD | PMID:21599003 and PMID:24001450 | Slc47a2 | Rat | ozone | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLC47A2 mRNA | CTD | PMID:34911549 | Slc47a2 | Rat | paracetamol | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC47A2 mRNA | CTD | PMID:29067470 | Slc47a2 | Rat | paraquat | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Paraquat inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | phenformin | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Phenformin inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | phentolamine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Phentolamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | procainamide | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Procainamide analog inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Procainamide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | proguanil | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Proguanil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | propranolol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Propranolol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | pyrimethamine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Pyrimethamine analog inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... | CTD | PMID:22419765 and PMID:32305507 | Slc47a2 | Rat | pyrimethamine | decreases activity | ISO | SLC47A2 (Homo sapiens) | 6480464 | Pyrimethamine results in decreased activity of SLC47A2 protein | CTD | PMID:32305507 | Slc47a2 | Rat | quinidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Quinidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | quinine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Quinine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | ranitidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Ranitidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | scopolamine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Scopolamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | serotonin | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Serotonin inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | silicon dioxide | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of SLC47A2 mRNA | CTD | PMID:25895662 | Slc47a2 | Rat | sotorasib | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC47A2 mRNA | CTD | PMID:36139627 | Slc47a2 | Rat | sulfadimethoxine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Sulfadimethoxine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | sulfamerazine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Sulfamerazine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | tacrine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Tacrine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | tetraethylammonium | increases import | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased import of Tetraethylammonium | CTD | PMID:28629854 | Slc47a2 | Rat | tetraethylammonium | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Amitriptyline inhibits the reaction [SLC47A2 protein results in increased import of Tetraethylammonium] more ... | CTD | PMID:22419765 more ... | Slc47a2 | Rat | tetraethylammonium | increases uptake | ISO | SLC47A2 (Homo sapiens) | 6480464 | SLC47A2 protein results in increased uptake of Tetraethylammonium | CTD | PMID:27989701 and PMID:32305507 | Slc47a2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC47A2 mRNA | CTD | PMID:34492290 | Slc47a2 | Rat | ticlopidine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Ticlopidine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | titanium dioxide | multiple interactions | ISO | Slc47a2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA | CTD | PMID:29950665 | Slc47a2 | Rat | titanium dioxide | decreases expression | ISO | SLC47A2 (Homo sapiens) | 6480464 | titanium dioxide results in decreased expression of SLC47A2 mRNA | CTD | PMID:34973136 | Slc47a2 | Rat | tramadol | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Tramadol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | trametinib | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC47A2 mRNA | CTD | PMID:36139627 | Slc47a2 | Rat | trichlormethiazide | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Trichlormethiazide affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | trimethoprim | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Trimethoprim inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | triptonide | increases expression | ISO | Slc47a2 (Mus musculus) | 6480464 | triptonide results in increased expression of SLC47A2 mRNA | CTD | PMID:33045310 | Slc47a2 | Rat | tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Atropine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | tyramine | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Tyramine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | CTD | PMID:22419765 | Slc47a2 | Rat | valproic acid | increases methylation | ISO | SLC47A2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SLC47A2 gene | CTD | PMID:29154799 | Slc47a2 | Rat | verapamil | decreases activity | ISO | SLC47A2 (Homo sapiens) | 6480464 | Verapamil results in decreased activity of SLC47A2 protein | CTD | PMID:28629854 and PMID:31364238 | Slc47a2 | Rat | verapamil | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] | CTD | PMID:22419765 and PMID:27989701 | Slc47a2 | Rat | zafirlukast | multiple interactions | ISO | SLC47A2 (Homo sapiens) | 6480464 | zafirlukast inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] | CTD | PMID:21599003 | |